MPR completes company registration and sets up a branch office in Japan.

.....................................................................................................................................................................

MPR to administer the emergency use of Peramivir under special regulatory approvals in selected countries.

.....................................................................................................................................................................

MPR and Yamamoto launch an international research project on expanding the application of Hyperthermia in the treatment of several indications of cancer.

.....................................................................................................................................................................

MPR Inc. launches several contract manufacturing projects to cover Asia markets needs.

.....................................................................................................................................................................

MPR Inc. launches Maximax Venture, an MPR division to manage Risk Sharing programs with Bio-Pharmaceutical companies.

.....................................................................................................................................................................

Maximax expands early phases clinical studies capabilities to Morocco, expands to Algeria and appoints Dr. Karim Jamali as a Regional Director. (PDF)

.....................................................................................................................................................................

MPR and Medidata partner to offer a solution to manage currency risks.

.....................................................................................................................................................................

MPR Inc. launches the Detroit Clinical Research Center as a site management organization, SMO.

.....................................................................................................................................................................

MPR Inc. launches portfolio development and risk sharing programs with several USA and UAE Bio-Pharma and Financial partners.

.....................................................................................................................................................................

MPR Inc. introduces a new methodology and process to manage currency risks in international clinical trials.

.....................................................................................................................................................................

MPR Inc. launches a call center in Bucharest Romania to manage patient management and screening and to support projects in Europe in Outcome Research.

.....................................................................................................................................................................

Maximax International, Inc. participated in the Smolensk Medical Conference.

.....................................................................................................................................................................

MPR Inc. launches an inpatient unit for clinical research.

.....................................................................................................................................................................

Maximax International, Inc. participated in the Rabat-Morocco conference and sponsored several activities including training and health programs in Morocco.

.....................................................................................................................................................................

Maximax to co-sponsor the First International Bucharest Stock Exchange Conference with focus on Bio-Pharma funds.

.....................................................................................................................................................................

MPR launches early phase clinical research capabilities in Michigan, USA.

.....................................................................................................................................................................

The Money Channel interviewed  Mr. Max Rashed, President & CEO.

.....................................................................................................................................................................

Maximax International, Inc. participated at the 42nd annual DIA conference held in Philadelphia.

.....................................................................................................................................................................